* Says no term-loan obligations due until 2012

* Debt a concern since Merck KGaA deal

NEW YORK, Jan 8  - Mylan Inc (MYL.O) paid $196 million of term-loan borrowings in December that had been been due in 2011, leaving it without any term-loan obligations due until 2012, the world's No. 3 generic drugmaker said on Friday.

Investors have been concerned about Mylan's debt load since the company's $6.8 billion acquisition in 2007 of the generics unit of Germany's Merck KGaA (MRCG.DE), a deal that vaulted Mylan to the top tier of the global generic drug industry. (Reporting by Lewis Krauskopf; Editing by Derek Caney)